Table 1.

Clinicopathologic parameters of the DLBCL patients in this stud

Variable	N (%)
Gender
Male	95(57.9)
Female	69(42.1)
Age (years)
> 60	39(23.8)
≤ 60	125(76.2)
Primary sites
Nodal	85(51.8)
Extranodal	79(48.2)
Stage
I–II	117(71.3)
III–IV	47(28.7)
Mass
Yes	30(18.3)
No	134(81.7)
B symptoms
Yes	39(23.8)
No	125(76.2)
LDH level
Elevated	49(30.8)
Normal	110(69.2)
Type
GCB	54(39.1)
Non-GCB	84(60.9)
IPI
0–1	82(51.6)
≥2	77(48.4)
Treatment response
CR	106(64.6)
Non-CR	58(35.4)

LDH, lactate dehydrogenase; GCB, Germinal center B-cell-like lymphoma;

IPI, International Prognostic Index; CR, Complete remission.